Mickey Ramchandani

Mickey Ramchandani has a diverse work experience spanning over several companies. Most recently, they held the role of Director of Corporate Development at West Pharmaceutical Services starting in 2022. Prior to this, Mickey worked at OBX Associates from 2014 to 2022 as a Business/Corporate Development, New Ventures, and Contracting Consultant. During their time at OBX Associates, they worked with various bio-pharmaceutical, diagnostic, and medical device companies, building business strategies, licensing, global commercial partnerships, and M&A, creating over $100M in value for clients. Mickey also served as the Chief Business Officer at Global Lyme Diagnostics from 2017 to 2020 and as a Corporate Development and Contracting Consultant at Quandary from 2015 to 2017. Mickey held the position of Vice President of Corporate Development/General Manager at TranS1/Baxano Surgical from 2008 to 2014 and played a key role in strategic planning, licensing, acquisition, and business development. Before that, they served as the Director of Business (Corporate) Development and Licensing at Kowa Research Institute from 2004 to 2008, where they led global collaborations and strategic partnerships. Mickey began their career at Baxter in 1998, where they held various roles, including Global Director of New Venture Development and Strategy, and achieved significant growth in sales and profit. Mickey also worked at Pfizer in drug development from 1990 to 1994. Overall, Mickey has a strong background in corporate development, strategy, licensing, and business development in the pharmaceutical and medical device industries.

Mickey Ramchandani holds an MBA in Global Marketing from UNC Kenan-Flagler Business School. Prior to this, they earned a BS in Chemistry from Campbell University and an MS in Organic Chemistry from East Carolina University.